PSA is a highly valuable biomarker of prostate cancer risk; however, there is a “grey zone” for PSA, where a slight elevation in PSA is not a reliable marker of prostate cancer; thus, the potential application of GOAT as a biomarker for prostate cancer diagnosis is very exciting [30,51,52,53]. This evidence concerns the gene KLK3 and prostate carcinoma.